文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

半胱天冬酶-8在干细胞移植减轻大鼠心肺复苏后大脑皮质凋亡中的作用

[Role of caspase-8 in stem cell transplantation alleviates rat cerebral cortex apoptosis after cardiopulmonary resuscitation].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2022-01-01
一句话结论大鼠窒息性心搏骤停/心肺复苏后,尾静脉移植骨髓间充质干细胞可能通过抑制死亡受体介导的凋亡通路(下调活性半胱天冬酶-8)减轻大脑皮质凋亡与脑损伤。

该研究用18只SD大鼠随机分为假手术组、模型组(心搏骤停/心肺复苏组)和干预组(骨髓间充质干细胞组),每组6只;窒息6分钟后行心肺复苏,复苏后1小时经尾静脉注射磷酸盐缓冲液或2×10⁹/L绿色荧光蛋白标记的骨髓间充质干细胞。复苏后3天,模型组较假手术组神经功能缺损评分降低(56.6±5.5 vs. 80.0±0.0,P<0.05)、血清S100B升高(45.1±4.7 vs. 19.1±1.4 ng/L,P<0.05)、皮质凋亡率升高[(52.9±11.8)% vs.(10.1±1.5)%,P<0.05]、活性半胱天冬酶-8升高(0.689±0.047 vs. 0.330±0.108,P<0.05),活性半胱天冬酶-9无显著差异(P>0.05)。移植后骨髓间充质干细胞主要分布于大脑皮质,干预组较模型组神经功能缺损评分升高(70.6±2.1 vs. 56.6±5.5,P<0.05)、血清S100B降低(32.0±3.2 vs. 45.1±4.7 ng/L,P<0.05)、凋亡率降低[(31.1±3.4)% vs.(52.9±11.8)%,P<0.05]、活性半胱天冬酶-8降低(0.427±0.067 vs. 0.689±0.047,P<0.05),活性半胱天冬酶-9两组无显著差异(P>0.05)。作者认为骨髓间充质干细胞移植可能通过抑制死亡受体介导的凋亡通路减轻大鼠心肺复苏后脑损伤。

要点

  • 大鼠窒息性心搏骤停6分钟后行心肺复苏,复苏后1小时经尾静脉注射2×10⁹/L绿色荧光蛋白标记的骨髓间充质干细胞0.5 mL。
  • 复苏后3天模型组较假手术组神经功能缺损评分降低(56.6±5.5 vs. 80.0±0.0,P<0.05),血清S100B升高(45.1±4.7 vs. 19.1±1.4 ng/L,P<0.05)。
  • 模型组较假手术组皮质凋亡率升高[(52.9±11.8)% vs.(10.1±1.5)%,P<0.05],活性半胱天冬酶-8升高(0.689±0.047 vs. 0.330±0.108,P<0.05),活性半胱天冬酶-9无显著差异(P>0.05)。
  • 干预组较模型组神经功能缺损评分升高(70.6±2.1 vs. 56.6±5.5,P<0.05)、血清S100B降低(32.0±3.2 vs. 45.1±4.7 ng/L,P<0.05)、凋亡率降低[(31.1±3.4)% vs.(52.9±11.8)%,P<0.05]、活性半胱天冬酶-8降低(0.427±0.067 vs. 0.689±0.047,P<0.05)。
  • 作者认为骨髓间充质干细胞移植可能通过抑制死亡受体介导的凋亡通路减轻大鼠心肺复苏后脑损伤。

适用人群与场景

  • 研究人群为4-5周龄Sprague-Dawley(SD)大鼠提取的骨髓间充质干细胞(取第3代用于实验),以及18只SD大鼠(假手术组、模型组、干预组各6只)。
  • 模型为窒息诱导心搏骤停6分钟后行心肺复苏的大鼠。

处置流程与药物剂量

  • 模型组于自主循环恢复后1小时经尾静脉注射0.5 mL磷酸盐缓冲液(PBS)。
  • 干预组于自主循环恢复后1小时经尾静脉注射2×10⁹/L绿色荧光蛋白(GFP)标记的骨髓间充质干细胞。
  • 假手术组除进行一般手术操作外不诱导心搏骤停。
  • 复苏后72小时评估神经功能缺损评分(NDS),并用酶联免疫吸附试验(ELISA)检测血清S100B水平。

研究设计与关键结果

  • 研究类型为大鼠实验研究,18只SD大鼠随机分为假手术组、模型组(心搏骤停/心肺复苏组)和干预组(骨髓间充质干细胞组),每组6只。
  • 复苏后3天,模型组较假手术组:NDS评分降低(56.6±5.5 vs. 80.0±0.0,P<0.05);血清S100B升高(45.1±4.7 vs. 19.1±1.4 ng/L,P<0.05);皮质细胞凋亡率升高[(52.9±11.8)% vs.(10.1±1.5)%,P<0.05];活性半胱天冬酶-8表达升高(caspase-8/GAPDH:0.689±0.047 vs. 0.330±0.108,P<0.05);活性半胱天冬酶-9表达无显著差异(caspase-9/GAPDH:0.428±0.014 vs. 0.426±0.021,P>0.05)。
  • 骨髓间充质干细胞移植后,绿色荧光蛋白标记的骨髓间充质干细胞主要见于大脑皮质。
  • 干预组较模型组:NDS评分升高(70.6±2.1 vs. 56.6±5.5,P<0.05);血清S100B降低(32.0±3.2 vs. 45.1±4.7 ng/L,P<0.05);皮质细胞凋亡率降低[(31.1±3.4)% vs.(52.9±11.8)%,P<0.05];活性半胱天冬酶-8表达降低(caspase-8/GAPDH:0.427±0.067 vs. 0.689±0.047,P<0.05)。
  • 干预组与模型组活性半胱天冬酶-9表达无显著差异(caspase-9/GAPDH:0.431±0.022 vs. 0.428±0.014,P>0.05)。

证据类型、等级与局限

  • 证据类型:大鼠实验研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为骨髓间充质干细胞移植可能通过抑制死亡受体介导的凋亡通路(下调活性半胱天冬酶-8)减轻大鼠心肺复苏后脑损伤。
  • 原文未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the effects and the possible mechanism of bone marrow mesenchymal stem cell (BMMSC) transplantation on apoptosis in rats cerebral cortex after cardiac arrest/cardiopulmonary resuscitation (CA/CPR).

METHODS: The BMMSC of 2 Sprague-Dawley (SD) rats aged 4-5weeks was extracted, and the 3rd passage was used in experimental study. Eighteen Sprague-Dawley (SD) rats were divided into sham group, model group (CA/CPR group) and intervention group (BMMSC group) according to random number table method, with 6 rats in each group. CPR was performed 6 minutes after asphyxia induced CA. In sham group, CA was not induced except performing general surgical procedure. At 1 hour after return of spontaneous circulation (ROSC), 0.5 mL phosphate buffered saline (PBS) was injected through tail vein in CA/CPR group. 2×109/L green fluorescence protein (GFP)-labeled BMMSC was injected through tail vein 1 hour after ROSC in BMMSC group. Neurological deficit score (NDS) were assessed in every group at 72 hours after CPR. Serum S100 calcium binding protein B (S100B) levels were assayed by enzyme linked immunosorbent assay (ELISA). Distribution of BMMSC in brain was observed under a fluorescent microscope. Apoptosis rate in cerebral cortex was assayed by TdT-mediated dUTP nick-end labeling (TUNEL). Western blotting was performed to measure the expression levels of active aspartic acid specific cysteine proteinase (caspase-8 and caspase-9) in cerebral cortex.

RESULTS: At 3 days after CPR, compared with sham group, the apoptosis of cerebral cortex cells was increased and brain damage was obvious, NDS score was decreased significantly (56.6±5.5 vs. 80.0±0.0, P < 0.05), and serum S100B was increased markedly (ng/L: 45.1±4.7 vs. 19.1±1.4, P < 0.05), apoptosis rate of cerebral cortex cells increased significantly [(52.9±11.8)% vs. (10.1±1.5)%, P < 0.05], the level of active caspase-8 expression in cerebral cortex was significantly higher (caspase-8/GAPDH: 0.689±0.047 vs. 0.330±0.108, P < 0.05), and there was no significant difference in active caspase-9 protein expression (caspase-9/GAPDH: 0.428±0.014 vs. 0.426±0.021, P > 0.05) in CA/CPR group. After BMMSC transplantation, GFP-labeled BMMSC were primarily detected in cerebral cortex, compared with CA/CPR group, the apoptosis of cerebral cortex cells and brain injury were significantly improved in BMMSC group, NDS score increased significantly (70.6±2.1 vs. 56.6±5.5, P < 0.05), serum S100B levels in BMMSC group were lower (ng/L: 32.0±3.2 vs. 45.1±4.7, P < 0.05), apoptosis rate of cerebral cortex cells decreased significantly [(31.1±3.4)% vs. (52.9±11.8)%, P < 0.05], and the active caspase-8 expression in cerebral cortex in BMMSC group was significantly decreased (caspase-8/GAPDH: 0.427±0.067 vs. 0.689±0.047, P < 0.05). The active caspase-9 expression in cerebral cortex in BMMSC group and CA/CPR group were not significantly different (caspase-9/GAPDH: 0.431±0.022 vs. 0.428±0.014, P > 0.05).

CONCLUSIONS: BMMSC transplantation can alleviate rat brain damage after CA/CPR possibly by inhibiting the death receptor mediated apoptotic pathway to inhibit the apoptosis of brain cells.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Lu E, Zhuo Q, Chen F, et al. [Role of caspase-8 in stem cell transplantation alleviates rat cerebral cortex apoptosis after cardiopulmonary resuscitation]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 36567583. doi:10.3760/cma.j.cn121430-20220411-00355

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。